Newsletters

Nanobusiness News

Nano Tech 2016: Teijin to Exhibit Advanced Nanotech Materials and Products

Nano Tech 2016: Teijin to Exhibit Advanced Nanotech Materials and Products

Teijin Limited announced today that it will exhibit a wide range of nanotech materials and products incorporating advanced Teijin technologies during the International Nanotechnology Exhibition and Conference (nano tech 2016), the world’s largest nanotechnology show, at Tokyo Big Sight in Tokyo, Japan from January 27 to 29.

Breakthrough NovaSpider 3D Spinning Machine for Nanofibre Production

Breakthrough NovaSpider 3D Spinning Machine for Nanofibre Production

Disruption: rupture or sudden interruption. Disruptive Innovation: is just what the Science Research Centre NanoGUNE has done, creating the NovaSpider 3D spinning machine, a breakthrough which is set to revolutionise the way nanofibres are produced. Why? Simple: because this machine enables the user to produce 3D structures based on state-of-the-art nanofibres in his/her own lab.

New Report on the Nanopharmaceutical Market

New Report on the Nanopharmaceutical Market

Do you want to find sales potentials of nanomedicine? If so, our new analysis gives you revenue forecasts to 2025 at overall world market, application, product and national level. That way you discover financial data, trends, R&D, opportunities and commercial outlooks.

Flexpoint Sensor Systems Passes Another Pre-Production Milestone with Multi-National Toy Manufacturer

Flexpoint Sensor Systems Passes Another Pre-Production Milestone with Multi-National Toy Manufacturer

Flexpoint Sensor Systems, Inc. (FLXT) today announced it has successfully passed another pre-production milestone with an American Fortune 500, multi-national toy manufacturing company.

Pharmasyntez Executes First Order of Oasmia’s Paclical Cancer Product in Russia

Pharmasyntez Executes First Order of Oasmia’s Paclical Cancer Product in Russia

Oasmia Pharmaceutical AB, a developer of a new generation of drugs within human and veterinary oncology, announced today that it its distribution partner, Pharmasyntez, has executed the first order of Paclical, Oasmia’s lead cancer product.

Graphene Technologies Developer, Carbon Sciences, Comments on Worldwide Information Technology Market

Graphene Technologies Developer, Carbon Sciences, Comments on Worldwide Information Technology Market

Carbon Sciences Inc., focused on developing breakthrough technologies based on graphene, the new miracle material, today commented on the extraordinary size of the worldwide information technology (IT) market.

Graphene Technologies Developer, Carbon Sciences, Comments on Worldwide Information Technology Market

Graphene Technologies Developer, Carbon Sciences, Comments on Worldwide Information Technology Market

FEI Company and DCG Systems, Inc. today announced a definitive agreement under which FEI would acquire DCG for $160 million in an all cash transaction. DCG is a leading supplier of electrical fault characterization, localization and editing equipment, serving process development, yield ramp and failure analysis applications for a wide range of semiconductor and electronics manufacturers. Headquartered in Fremont, California, DCG is a profitable private company and was the recipient of Deloitte’s Technology Fast 500 award in 2013 and 2014.

BIND Therapeutics’ Four Abstracts Accepted for Presentation at AACR-NCI-EORTC International Conference

BIND Therapeutics’ Four Abstracts Accepted for Presentation at AACR-NCI-EORTC International Conference

BIND Therapeutics, Inc., a clinical-stage nanomedicine company developing targeted and programmable therapeutics called Accurins™, today announced that four abstracts have been accepted for presentation at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics being held in Boston, November 5-9, 2015.

Senior Scientific Awarded Chinese Patent for Nanoparticle-Based Early Cancer Detection Technology Platform

Senior Scientific Awarded Chinese Patent for Nanoparticle-Based Early Cancer Detection Technology Platform

Senior Scientific, LLC, a unit of Manhattan Scientifics and a developer of nanobiotechnology for the early detection and localization of cancer and other human diseases, today announced that the Company has recently been granted a patent by the Chinese Patent Office, Patent No. CN102695473 A, covering the "Detection, measurement, and imaging of cells such as cancer and other biologic substances using targeted nanoparticles and magnetic properties thereof."

The University of Bristol Awarded Funding to Build UK’s First NanoESCA System

The University of Bristol Awarded Funding to Build UK’s First NanoESCA System

Bristol has been awarded funding to build the UK’s first NanoESCA system by the EPSRC’s Strategic Equipment Panel, including a collaboration to develop tuneable X-ray electron spectroscopy.